Product NDC: | 42549-532 |
Proprietary Name: | CLINDAMYCIN HYDROCHLORIDE |
Non Proprietary Name: | CLINDAMYCIN HYDROCHLORIDE |
Active Ingredient(s): | 150 mg/1 & nbsp; CLINDAMYCIN HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42549-532 |
Labeler Name: | STAT Rx USA LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065061 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010202 |
Package NDC: | 42549-532-28 |
Package Description: | 28 CAPSULE in 1 BOTTLE (42549-532-28) |
NDC Code | 42549-532-28 |
Proprietary Name | CLINDAMYCIN HYDROCHLORIDE |
Package Description | 28 CAPSULE in 1 BOTTLE (42549-532-28) |
Product NDC | 42549-532 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CLINDAMYCIN HYDROCHLORIDE |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20010202 |
Marketing Category Name | ANDA |
Labeler Name | STAT Rx USA LLC |
Substance Name | CLINDAMYCIN HYDROCHLORIDE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |